The Food and Drugs Authority (FDA) has officially announced the appointment of Professor Kwabena Frimpong-Manso Opuni as its new Acting Chief Executive Officer (CEO), effective Monday, July 14, 2025.
Prof. Opuni assumes leadership of the Authority following the departure of Dr. Delese Mimi Darko, who has served as CEO since 2017. Dr. Darko was recently appointed as the Director General of the Africa Medicines Agency (AMA), a significant elevation in her distinguished career in public health and regulatory governance.
Before taking on his new role, Prof. Opuni served as the Board Chairman of the FDA. He brings to the position a wealth of experience in public health policy, regulatory affairs, and institutional leadership.
In an official statement, the FDA extended its warmest congratulations to Prof. Opuni and expressed confidence in his leadership to drive the Authority’s mission of protecting public health and safety.
“Prof. Opuni’s deep understanding of regulatory systems and his track record in governance position him to build on the solid foundation laid by Dr. Darko,” the statement read.
His appointment comes at a pivotal time as the FDA intensifies efforts to strengthen its regulatory framework, promote consumer safety, and ensure the quality and efficacy of food, pharmaceuticals, cosmetics, and other regulated products across Ghana
